One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes.
autoantibody
diagnosis
metabolic risk
oral glucose tolerance test
prediction
type 1 diabetes
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 11 2020
01 11 2020
Historique:
received:
21
08
2020
accepted:
21
08
2020
pubmed:
28
8
2020
medline:
17
2
2021
entrez:
27
8
2020
Statut:
ppublish
Résumé
Once islet autoantibody-positive individuals are identified, predicting which individuals are at highest risk for type 1 diabetes (T1D) is important. A metabolic risk score derived from 2-hour oral glucose tolerance test (OGTT) data, the Diabetes Prevention Trial-Type 1 risk score (DPTRS), can accurately predict T1D. However, 2-hour OGTTs are time-consuming and costly. We aimed to determine whether a risk score derived from 1-hour OGTT data can predict T1D as accurately as the DPTRS. Secondarily, we evaluated whether a 1-hour glucose value can be used for diagnostic surveillance. The DPTRS was modified to derive a 1-hour OGTT risk score (DPTRS60) using fasting C-peptide, 1-hour glucose and C-peptide, age, and body mass index. Areas under receiver operating curves (ROCAUCs) were used to compare prediction accuracies of DPTRS60 with DPTRS in Diabetes Prevention Trial-Type 1 (DPT-1) (n = 654) and TrialNet Pathway to Prevention (TNPTP) (n = 4610) participants. Negative predictive values (NPV) for T1D diagnosis were derived for 1-hour glucose thresholds. ROCAUCs for T1D prediction 5 years from baseline were similar between DPTRS60 and DPTRS (DPT-1: 0.805 and 0.794; TNPTP: 0.832 and 0.847, respectively). DPTRS60 predicted T1D significantly better than 2-hour glucose (P < .001 in both cohorts). A 1-hour glucose of less than 180 mg/dL had a similar NPV, positive predictive value, and specificity for T1D development before the next 6-month visit as the standard 2-hour threshold of less than 140 mg/dL (both ≥ 98.5%). A 1-hour OGTT can predict T1D as accurately as a 2-hour OGTT with minimal risk of missing a T1D diagnosis before the next visit.
Identifiants
pubmed: 32844178
pii: 5897237
doi: 10.1210/clinem/dgaa592
pmc: PMC7514797
pii:
doi:
Substances chimiques
Autoantibodies
0
Blood Glucose
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : U01 DK085476
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061010
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085499
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085463
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103266
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK106993
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061042
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085509
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK117009
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085466
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103153
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061058
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085505
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085453
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061034
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085461
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103180
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085465
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085504
Pays : United States
Informations de copyright
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Diabetes Care. 2005 May;28(5):1068-76
pubmed: 15855569
Stat Med. 2013 Dec 30;32(30):5381-97
pubmed: 24027076
Diabetes Care. 2008 Nov;31(11):2188-92
pubmed: 18650369
N Engl J Med. 2002 May 30;346(22):1685-91
pubmed: 12037147
JAMA. 2020 Jan 28;323(4):339-351
pubmed: 31990315
Diabetes Care. 2014 Apr;37(4):979-84
pubmed: 24550217
Diabetes Care. 2017 Nov;40(11):1494-1499
pubmed: 28860125
Curr Diab Rep. 2015 Aug;15(8):49
pubmed: 26077017
Pediatr Diabetes. 2016 Sep;17(6):441-8
pubmed: 26251221
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Diabetes Care. 2015 Oct;38(10):1964-74
pubmed: 26404926
J Clin Endocrinol Metab. 2010 Jul;95(7):3360-7
pubmed: 20444913
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1701-6
pubmed: 10677521
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5
pubmed: 17942684
Diabetes. 2010 Oct;59(10):2386-9
pubmed: 20682683
Diabetes. 2001 Feb;50(2):470-6
pubmed: 11272162
Pediatr Diabetes. 2019 Nov;20(7):909-914
pubmed: 31376227